>>256
ïœåœç«ææçç 究æHPããåŒçšïœ
èå¯ æ¬å ±åã§ã¯ãV-SYSãšHER-SYSã®ããŒã¿ãçšããŠæ°åã³ããã¯ã¯ãã³BNT162b2ãæ¥çš®ããå»çåŸäºè
ã®ä»®æ³ã³ããŒããæ§æã1åç®æ¥çš®åŸã®COVID-19å ±åçãæ€èšãããå ±åçã¯1åç®æ¥çš®æ¥ãã12æ¥ååŸãå¢ã«äœäžããåŸåãã¿ãããæ¥çš®åŸ0-13æ¥ã®å ±åçãšæ¯èŒãããšã14-20æ¥ã§0.42åïŒ95%CI: 0.30-0.59ïŒã21-27æ¥ã§0.39åïŒ95%CI: 0.27-0.56ïŒã28æ¥ä»¥éã§0.14åïŒ95%CI: 0.09-0.21ïŒã§ãã£ããæ¬å ±åã®åæã§ã¯æ¯èŒå¯Ÿè±¡ãšãªãã¯ã¯ãã³éæ¥çš®è
ã®COVID-19å ±åçã®æ
å ±ããªãããšãããBNT162b2ã®VEãçŽæ¥çã«æšå®ããããšã¯ã§ããªããããããBNT162b2ã¯1åç®æ¥çš®ããèšåºçå¹æãçºçŸãããŸã§ã«12æ¥ååŸãèŠãããšããå
è¡ç 究ã®çµæãããŠã¯ãããšïŒ2,3ïŒããã®çµæã¯å¯Ÿè±¡è
ã«ãããŠæ¥çš®åŸ14æ¥ä»¥éã«COVID-19å ±åçãçŽ60%æžå°ããããšã«çžåœãããã€ã¹ã©ãšã«ã§è¡ãããå
è¡ç 究ã§ã¯ã1åç®æ¥çš®åŸãã2åç®æ¥çš®ãŸã§ã®æéã®VEã¯46-60%ã§ãã£ããšå ±åãããŠãããæ¬å ±åã®çµæã¯ãããšåçã§ããå¯èœæ§ããã(3)ã
HER-SYSã«ç»é²ãããå°ãªããšã1åã®ã¯ã¯ãã³æ¥çš®æŽãèšé²ãããŠããCOVID-19çäŸ281äŸäžãã¯ã¯ãã³æ¥çš®åŸ28æ¥ä»¥å
ã«èšºæãããçäŸã¯256äŸïŒ91.1%ïŒã§ãã£ããçäŸã¯å¥³æ§ããã³20-40æ³ä»£ãçŽ7å²ãå ããŠããïŒè¡š1ïŒã2åç®ã®æ¥çš®åŸã«èšºæãããçäŸã¯å
šäœã®16.7%
ïœåŒçšçµããïœ
ããŒã¿ãã
2æ17æ¥ïœ4æ11æ¥ãŸã§ã®éã«
256äŸäžäžåæ¥çš®åŸã«éœæ§ã«ãªã£ã人ã¯233人
ãã®ãã¡60ïœ69æ³ã¯16人â6.9%
äºåæ¥çš®åŸéœæ§ã«ãªã£ã人ã¯23人
ãã®ãã¡60ïœ69æ³ã¯1人â4.3%
28æ¥ä»¥éã«ã€ããŠã¯ã60ïœ69æ³ã§ã¯éœæ§è
ã¯0ã ãã0%ãšãªãã
矀銬ç9æã®5æ¥éã ãã§ãéœæ§è
å
šäœã«å¯Ÿã60æ³ä»¥äžã6.8%ãšããã®ã¯
4ææç¹ãã確çãããã£ãŠãããšèŠãããšãåºæ¥ãã®ã§ã¯ã
ã©ã¡ãã«ããŠã60æ³ä»£ã¯æ¥çš®åŸéœæ§ã«ãªã人ãäžçªå°ãªã幎代ãšããããšã¯ããã£ãã